GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC
Clinical trial NCT05023109 · UNKNOWN
Trial details
- NCT number
- NCT05023109
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2023-01-18
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.